All News about Neogenomics Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_150.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/cancer.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/lab.julia-koblitz-rloawxt2fea-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220329005654/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://www.investors.com/wp-content/uploads/2018/02/Stock-drug-03-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_4009.png?width=1200&height=800&fit=crop)
Why NeoGenomics Stock Is Plunging Today
March 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_5374.jpeg)
![](https://cdn.benzinga.com/files/images/story/2012/mid-morning-market-update_158.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2641.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1784.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5706.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/price_targets_409.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_5347.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5702.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/cells-gdd37bc5d2_1920_19.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_583.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://mms.businesswire.com/media/20220328005917/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220328005897/en/785856/5/Blue_Box_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_5330.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/14286.jpg?v=0)
NeoGenomics Announces CEO Departure and Initiates CEO Search
March 28, 2022
From NeoGenomics, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/14286.jpg?v=0)
From NeoGenomics, Inc.
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_664.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/14286.jpg?v=0)
From NeoGenomics, Inc.
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2012/price_targets_386.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/lab-5740505_1920_4.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/14286.jpg?v=0)
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
February 23, 2022
From NeoGenomics, Inc.
Via AccessWire
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech7.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1761.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.